Advertisement

Irritable Bowel Syndrome

  • Yehudith Assouline-DayanEmail author
Chapter

Abstract

Irritable bowel syndrome or IBS is characterized by chronic abdominal pain that is related to defecation and altered bowels. The disorder is better defined as altered gut-brain interaction than as a functional gastrointestinal (GI) disorder. When diagnosing IBS by the Rome criteria and not by exclusion through extensive testing, the accuracy of the diagnosis in 98%. Nonetheless, if the provider decides to proceed with testing and results are negative, one should try to refrain from statements such as “your pain is still an enigma” or “I could not find a GI source for your pain” as these statements lead to more unnecessary testing and increase patient’s anxiety. Rather, we need to spend time talking to the patient and discuss the different mechanisms that underlie the development of IBS. The first and most cardinal step in treating a patient with IBS relies on establishing a good doctor patient relationship and addressing patient’s concerns.

Living with IBS is not an easy task and some patients are overwhelmed by the ongoing need of dealing with recurrent or daily symptoms, which are at times unexpected and debilitating. Even though we don’t cure IBS, there are many treatment options we can choose from either medical, non-medical or a combination. Once we have tailored treatment plan to patient’s needs, individual preferences, and beliefs, and we engage the patient in the treatment plan, there is a good chance we will help him improve his symptoms, quality of life, and global function.

Keywords

IBS IBS-C IBS-D FODMAP TCA Linaclotide Lubiprostone Xifaxan Viberzi CBT 

References

  1. 1.
    Drossman DA, Hasler WL. Rome IV—functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257–61.CrossRefPubMedGoogle Scholar
  2. 2.
    Agarwal N, Spiegel BM. The effect of irritable bowel syndrome on health-related quality of life and health care expenditures. Gastroenterol Clin N Am. 2011;40(1):11–9.CrossRefGoogle Scholar
  3. 3.
    Henström M, D'Amato M. Genetics of irritable bowel syndrome. Mol Cell Pediatr. 2016;3(1):7.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Chitkara DK, van Tilburg MA, Blois-Martin N, Whitehead WE. Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol. 2008;103(3):765–74.CrossRefPubMedGoogle Scholar
  5. 5.
    Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology. 1995;109(1):40–52.CrossRefPubMedGoogle Scholar
  6. 6.
    Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD, Ameen VZ, Mayer EA. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil. 2009;21(2):149–59.CrossRefPubMedGoogle Scholar
  7. 7.
    Piche T. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation. Neurogastroenterol Motil. 2014;26(3):296–302.CrossRefPubMedGoogle Scholar
  8. 8.
    Spiller R, Lam C. An update on post-infectious irritable bowel syndrome: role of genetics, immune activation, serotonin and altered Microbiome. J Neurogastroenterol Motil. 2012;18(3):258–68.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(9):1350–65.CrossRefPubMedGoogle Scholar
  10. 10.
    Pinn D, Aroniadis O, Brandt LJ. Follow-up study of fecal microbiota transplantation (FMT) for the treatment of refractory irritable bowel syndrome (IBS). Am J Gastroenterol. 2013;108(Suppl 1s):S1862.Google Scholar
  11. 11.
    Prusator DK, Andrews A, Greenwood-Van Meerveld B. Neurobiology of early life stress and visceral pain: translational relevance from animal models to patient care. Neurogastroenterol Motil. 2016;28(9):1290–305.CrossRefPubMedGoogle Scholar
  12. 12.
    El-Serag HB, Pilgrim P, Schoenfeld P. Systemic review: natural history of irritable bowel syndrome. Aliment Pharmacol Ther. 2004;19(8):861–70.CrossRefPubMedGoogle Scholar
  13. 13.
    Shivaji UN, Ford AC. Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality. Prim Health Care Res Dev. 2015;16(3):263–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, Cash BD. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol. 2010;105(4):859–65.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology. 2004;126(7):1721–32.CrossRefPubMedGoogle Scholar
  16. 16.
    Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, Simrén M. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015;149(6):1399–407.CrossRefPubMedGoogle Scholar
  17. 17.
    Nanayakkara WS, Skidmore PM, O'Brien L, Wilkinson TJ, Gearry RB. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 2016;9:131–42.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013;108:634–41.CrossRefPubMedGoogle Scholar
  19. 19.
    Biesiekierski JR, Newnham ED, Irving PM, Barrett JS, Haines M, Doecke JD, Shepherd SJ, Muir JG, Gibson PR. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol. 2011;106(3):508–14.CrossRefPubMedGoogle Scholar
  20. 20.
    Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013;145(2):320–8.CrossRefPubMedGoogle Scholar
  21. 21.
    Drossman DA. 2012 David sun lecture: helping your patient by helping yourself—how to improve the patient–physician relationship by optimizing communication skills. Am J Gastroenterol. 2013;108:521–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Nagarajan N, Morden A, Bischof D, King EA, Kosztowski M, Wick EC, Stein EM. The role of fiber supplementation in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2015;27(9):1002–10.CrossRefPubMedGoogle Scholar
  23. 23.
    Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2011;(8) doi: 10.1002/14651858.CD003460.pub3.
  24. 24.
    Morgan V, Pickens D, Gautam S, Kessler R, Mertz H. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut. 2005;54(5):601–7.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Castro J, Harrington AM, Hughes PA, Martin CM, Ge P, Shea CM, Jin H, Jacobson S, Hannig G, Mann E, Cohen MB, MacDougall JE, Lavins BJ, Kurtz CB, Silos-Santiago I, Johnston JM, Currie MG, Blackshaw LA, Brierley SM. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3′,5′-monophosphate. Gastroenterology. 2013;145(6):1334–46.CrossRefPubMedGoogle Scholar
  26. 26.
    Lacy BE. Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med. 2016;9:7–17.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Vahedi H, Merat S, Momtahen S, Kazzazi AS, Ghaffari N, Olfati G, Malekzadeh R. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2008;27:678–84.CrossRefPubMedGoogle Scholar
  28. 28.
    Chey WD, Chey WY, Heath AT, Dukes GE, Carter EG, Northcutt A, Ameen VZ. Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2004;99(11):2195–203.CrossRefPubMedGoogle Scholar
  29. 29.
    Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, Mareya SM, Shaw AL, Bortey E, Forbes WP, TARGET Study Group. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364(1):22–32.CrossRefPubMedGoogle Scholar
  30. 30.
    Lembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA, Davenport JM, McIntyre G, Lopez R, Turner L, Covington PS. Eluxadoline for irritable bowel syndrome with diarrhea. N Engl J Med. 2016;374(3):242–53.CrossRefPubMedGoogle Scholar
  31. 31.
    Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Quigley EM. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109(Suppl 1):S2–26.CrossRefPubMedGoogle Scholar
  32. 32.
    Lembo AJ, Conboy L, Kelley JM, Schnyer RS, McManus CA, Quilty MT, Kerr CE, Drossman D, Jacobson EE, Davis RB. A treatment trial of acupuncture in IBS patients. Am J Gastroenterol. 2009;104(6):1489–97.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Peckham EJ, Nelson EA, Greenhalgh J, Cooper K, Roberts ER, Agrawal A. Homeopathy for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2013; doi: 10.1002/14651858.CD009710.pub2.

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Division of Gastroenterology-Hepatology, Department of Internal MedicineUniversity of Iowa Hospital and ClinicsIowa CityUSA

Personalised recommendations